Snap is trading at $5.71, down 4.11%, amid broader technology weakness.

  • No new Snap-specific catalyst surfaced for October 29. The youth-addiction trial began October 28; coverage tied the prior session’s decline to the trial, not today’s move.
  • Technology shares fell amid renewed AI-spending concerns after disappointing Alphabet results, and the Nasdaq was down more than 0.5%. The trial remains background, not a confirmed cause today.